ERK4/MAPK4 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-58082
Key Product Details
Species Reactivity
Validated:
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.5 mg/ml
Product Summary for ERK4/MAPK4 Antibody
Immunogen
Synthetic peptides corresponding to MAPK4(mitogen-activated protein kinase 4) The peptide sequence was selected from the middle region of MAPK4. Peptide sequence DFLEKILTFNPMDRLTAEMGLQHPYMSPYSCPEDEPTSQHPFRIEDEIDD. The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for ERK4/MAPK4 Antibody
Western Blot: ERK4/MAPK4 Antibody [NBP1-58082]
Western Blot: ERK4/MAPK4 Antibody [NBP1-58082] - Human Heart lysate, concentration 0.2-1 ug/ml.Applications for ERK4/MAPK4 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: ERK4
Long Name
Extracellular Signal-regulated Kinase A
Alternate Names
MAPK4, p63Mapk, PRKM4
Gene Symbol
MAPK4
UniProt
Additional ERK4 Products
Product Documents for ERK4/MAPK4 Antibody
Product Specific Notices for ERK4/MAPK4 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...